Blog Grid

Latest Pharmaceutical News & Insights

New Mefloquine Production Facility Opens in Mumbai

Taj Pharma announces the opening of a state-of-the-art mefloquine production facility, expanding our capacity to meet global demand for malaria prevention medications.

Read More

WHO Updates Guidelines for Mefloquine Usage

The World Health Organization has updated its guidelines for mefloquine usage in malaria prevention, emphasizing proper dosage and administration protocols.

Read More

Groundbreaking Clinical Research Results Published

Recent clinical trials demonstrate enhanced efficacy of Taj Pharma's mefloquine formulations with reduced side effects and improved patient compliance.

Read More

Global Distribution Network Expands to 50 Countries

Taj Pharma's global distribution network now reaches 50 countries, ensuring reliable access to quality mefloquine medications worldwide.

Read More

Innovative Quality Control Systems Implemented

Taj Pharma introduces AI-powered quality control systems to ensure the highest standards in mefloquine production and batch consistency.

Read More

Sustainable Manufacturing Practices Reduce Carbon Footprint

Taj Pharma's commitment to environmental sustainability results in 30% reduction in carbon footprint while maintaining production efficiency.

Read More